These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12242073)

  • 1. Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction.
    Ronner E; van Domburg RT; van den Brand MJ; de Feyter PJ; Foley DP; van der Giessen WJ; Serruys PW; Simoons ML
    Eur Heart J; 2002 Oct; 23(19):1529-37. PubMed ID: 12242073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet GPIIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies.
    Mahadevan VS; McCarty D; Adgey AA
    Eur Heart J; 2002 Oct; 23(19):1490-1. PubMed ID: 12242068
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysis.
    Di Pasquale P; Cannizzaro S; Scalzo S; Maringhini G; Vitrano GM; Giubilato A; Giambanco F; Sarullo FM; Paterna S
    Int J Cardiol; 2003 Dec; 92(2-3):265-70. PubMed ID: 14659863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study.
    Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S
    Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoprotein IIb/IIIa inhibitors during rescue percutaneous coronary intervention in acute myocardial infarction.
    Gruberg L; Suleiman M; Kapeliovich M; Hammerman H; Grenadier E; Boulus M; Amikam S; Markiewicz W; Beyar R
    J Invasive Cardiol; 2006 Feb; 18(2):59-62. PubMed ID: 16446517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty.
    Bonello L; de Labriolle A; Roy P; Steinberg DH; Pinto Slottow TL; Xue Z; Kaneshige K; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2009; 10(3):156-61. PubMed ID: 19595396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access-site complications after rescue percutaneous coronary intervention during thrombolysis for acute myocardial infarction.
    Germing A; Lindstaedt M; Ulrich S; Bojara W; Lawo T; Mügge A; Grewe P
    Z Kardiol; 2005 Jan; 94(1):23-7. PubMed ID: 15668826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty].
    Kala P; Poloczek M; Bocek O; Jerábek P; Neugebauer P; Kosová J; Semrád B
    Vnitr Lek; 2002 Aug; 48(8):736-41. PubMed ID: 12425204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction.
    Bosch X; Marrugat J
    Cochrane Database Syst Rev; 2001; (4):CD002130. PubMed ID: 11687143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein IIb/IIIa antagonists in the setting of rescue percutaneous coronary intervention.
    Arora UK; Conde I; Kleiman NS
    J Interv Cardiol; 2002 Apr; 15(2):155-62. PubMed ID: 12063811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty.
    Uyarel H; Uzunlar B; Unal Dayi S; Tartan Z; Samur H; Kasikcioglu H; Akgul O; Simsek D; Erdem I; Okmen E; Cam N
    Cardiology; 2006; 105(3):168-75. PubMed ID: 16479104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet glycoprotein IIb/IIIa inhibitors in rescue percutaneous coronary interventions.
    Petronio AS; De Carlo M; Rossini R; Amoroso G; Limbruno U; Ciabatti N; Palagi C; Caravelli P; Mariani M
    Ital Heart J; 2004 Feb; 5(2):114-9. PubMed ID: 15086140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of rescue angioplasty for ST-elevation myocardial infarction with high utilization rates of glycoprotein IIb/IIIa inhibitors.
    Shugman IM; Hsieh V; Cheng S; Parikh D; Tobing D; Wouters N; van der Vijver R; Lo Q; Rajaratnam R; Hopkins AP; Lo S; Leung D; Juergens CP; French JK
    Am Heart J; 2012 Apr; 163(4):649-56.e1. PubMed ID: 22520531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between therapeutic time intervals and intermediate term left ventricular systolic function in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction.
    Meyborg P; Abdel-Wahab M; Herrmann G; Geist V; Khattab AA; Krüger D; Lins M; Toelg R; Simon R; Richardt G
    Clin Res Cardiol; 2007 Feb; 96(2):94-102. PubMed ID: 17160565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction.
    Gershlick AH; Stephens-Lloyd A; Hughes S; Abrams KR; Stevens SE; Uren NG; de Belder A; Davis J; Pitt M; Banning A; Baumbach A; Shiu MF; Schofield P; Dawkins KD; Henderson RA; Oldroyd KG; Wilcox R;
    N Engl J Med; 2005 Dec; 353(26):2758-68. PubMed ID: 16382062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radial versus femoral access for rescue percutaneous coronary intervention with adjuvant glycoprotein IIb/IIIa inhibitor use.
    Kassam S; Cantor WJ; Patel D; Gilchrist IC; Winegard LD; Rea ME; Bowman KA; Chisholm RJ; Strauss BH
    Can J Cardiol; 2004 Dec; 20(14):1439-42. PubMed ID: 15614338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.
    Schömig A; Kastrati A; Dirschinger J; Mehilli J; Schricke U; Pache J; Martinoff S; Neumann FJ; Schwaiger M
    N Engl J Med; 2000 Aug; 343(6):385-91. PubMed ID: 10933737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein IIb/IIIa receptor inhibitor-thrombolytic combination therapy for acute myocardial infarction.
    Maranian AM; Steinhubl SR
    Curr Cardiol Rep; 2002 Jul; 4(4):313-9. PubMed ID: 12052270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.